Kerala Ayurveda Ltd.
| BSE: 530163 | Sector: Health care |
| NSE: N.A. | ISIN Code: INE817B01025 |
| BSE LIVE 10:48 | 24 Oct | 103.00 |
2.15 (2.13%) |
OPEN
104.95 |
HIGH
104.95 |
LOW
95.10 |
| NSE 05:30 | 01 Jan | Stock Is Not Traded. |
| OPEN | 104.95 |
| PREVIOUS CLOSE | 100.85 |
| VOLUME | 11874 |
| 52-Week high | 122.80 |
| 52-Week low | 56.00 |
| P/E | 56.91 |
| Mkt Cap.(Rs cr) | 109 |
| Buy Price | 103.00 |
| Buy Qty | 85.00 |
| Sell Price | 103.50 |
| Sell Qty | 104.00 |
Kerala Ayurveda Ltd. (KERALAAYURVEDA) - Net Profit
Net Profit
| COMPANY | LATEST(Rs) | CHG | CHG(%) | Net Profit (Rs crore) |
| Lupin | 1034.05 | -2.65 | -0.26 | 3141.33 |
| Glenmark Pharma. | 600.00 | 1.35 | 0.23 | 2140.61 |
| Aurobindo Pharma | 754.75 | 4.25 | 0.57 | 1706.76 |
| Dr Reddy's Labs | 2365.50 | 0.65 | 0.03 | 1384.10 |
| Divi's Lab. | 866.95 | -6.80 | -0.78 | 1053.27 |
| Cipla | 594.50 | 0.80 | 0.13 | 974.94 |
| Alkem Lab | 1852.35 | -3.55 | -0.19 | 883.16 |
| Torrent Pharma. | 1374.95 | 2.15 | 0.16 | 854.22 |
| Piramal Enterp. | 2748.55 | 12.20 | 0.45 | 776.78 |
| Cadila Health. | 484.60 | -6.55 | -1.33 | 661.90 |
| Biocon | 364.20 | 0.65 | 0.18 | 519.30 |
| Ajanta Pharma | 1145.00 | -28.20 | -2.40 | 499.81 |
| Natco Pharma | 987.55 | -3.10 | -0.31 | 494.80 |
| Alembic Pharma | 492.50 | -3.45 | -0.70 | 430.63 |
| Glaxosmi. Pharma | 2437.40 | 1.55 | 0.06 | 336.78 |
| Pfizer | 1721.60 | 5.90 | 0.34 | 336.78 |
| Sanofi India | 4217.00 | -4.60 | -0.11 | 297.00 |
| Syngene Intl. | 501.25 | 3.95 | 0.79 | 287.30 |
| Apollo Hospitals | 1057.10 | -4.55 | -0.43 | 285.15 |
| Abbott India | 4169.45 | 11.15 | 0.27 | 276.65 |
Quick Links for Kerala Ayurveda:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
